Arkolith/Insider Trading/TNYA/Form 4

Goeddel David V

Director, 10% OwnerTenaya Therapeutics, Inc. (TNYA) · full profile →Form 4 · filed Mar 7, 2025
Net Buying
Open-Market Buys
$25.0M
Open-Market Sells
$0
Net Open-Market Flow
$25.0M
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 5, 2025Buy(P)35.7M$0.70$25.0M49.3M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 5, 2025Buy(P)35.7M——35.7M
Mar 5, 2025Buy(P)17.9M——17.9M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-035788) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML